Jérôme Wojcik

Title: The Innovative Contributions of Jérôme Wojcik

Introduction

Jérôme Wojcik is a notable inventor based in Divonne Les Bains, France. He has made significant contributions to the field of cancer therapy through his innovative research and patenting efforts. His work focuses on methods that target specific polypeptides to improve cancer treatment outcomes.

Latest Patents

Wojcik holds a patent for "Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)." This patent describes fusion polypeptides that include an FGFR2 polypeptide and cDNAs that encode such fusion polypeptides. The methods outlined in the patent also include diagnosing the presence of these fusion polypeptides or related gene or RNA sequences in samples from subjects, as well as treatment methods for tumors based on this diagnosis. He has 1 patent to his name.

Career Highlights

Wojcik's career has been marked by his dedication to advancing cancer therapies. His innovative approaches have the potential to significantly impact the treatment landscape for patients suffering from various forms of cancer. His work at Debiopharm International S.A. has allowed him to collaborate with other experts in the field.

Collaborations

Some of his notable coworkers include Hiroaki Tanaka and Corinne Moulon. Their collaborative efforts contribute to the ongoing research and development of effective cancer therapies.

Conclusion

Jérôme Wojcik's contributions to cancer therapy through his innovative patent work exemplify the importance of research and collaboration in the medical field. His dedication to improving treatment options for patients is commendable and highlights the vital role of inventors in advancing healthcare solutions.